StockNews.AI
TMDX
StockNews.AI
175 days

TransMedics Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX

1. Investors notified of class action lawsuit alleging securities fraud against TMDX. 2. Complaint cites kickbacks, fraudulent overbilling, and unsafe practices in operations. 3. Lawsuit covers losses from Feb 2023 to Jan 2025; lead plaintiff deadline is April 15, 2025.

4m saved
Insight
Article

FAQ

Why Bearish?

The lawsuit introduces significant legal and regulatory risk, likely undermining investor confidence. Similar securities fraud cases have triggered steep short‐term declines in stock prices.

How important is it?

The serious allegations could lead to investor selloffs and regulatory scrutiny, impacting price in the short run, though final outcomes remain dependent on litigation resolution.

Why Short Term?

Immediate uncertainty and potential settlement issues are expected to affect TMDX in the near term, though long-term fundamentals may stabilize after resolution.

Related Companies

NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in TransMedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ: TMDX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of TransMedics investors who were adversely affected by alleged securities fraud between February 28, 2023 and January 10, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=131769&wire=4 TMDX investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) TransMedics used kickbacks, fraudulent overbilling, and coercive tactics to generate business and revenue; (2) TransMedics engaged in unsafe practices and hid safety issues and generally lacked safety oversight; (3) the foregoing subjected TransMedics to heightened risk of scrutiny and regulatory risk; and (4) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. WHAT'S NEXT? If you suffered a loss in TransMedics during the relevant time frame, you have until April 15, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. CONTACT:Levi & Korsinsky, LLP Joseph E. Levi, Esq.Ed Korsinsky, Esq.33 Whitehall Street, 17th FloorNew York, NY 10004[email protected]Tel: (212) 363-7500Fax: (212) 363-7171www.zlk.com SOURCE Levi & Korsinsky, LLP

Related News